CRO · Private company
PSI CRO
Track this companyFree. Adds PSI CRO to your Dealase workspace and tells you when its record changes.
Clinical trials76 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- Flutemetamol F 18 Injection Formulation ComparisonPHASE2 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07873463 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)PHASE3 · RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07742735 · fetched Nov 12, 2026
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)PHASE2 · RECRUITING · started May 28, 2025ClinicalTrials.gov NCT06782373 · fetched Nov 12, 2026
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPHASE1_PHASE2 · RECRUITING · started Jul 20, 2022ClinicalTrials.gov NCT05413850 · fetched Nov 12, 2026
- Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian CancerPHASE1 · TERMINATED · started Jun 11, 2021ClinicalTrials.gov NCT04907968 · fetched Nov 12, 2026
- A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia MyelofibrosisPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 26, 2017ClinicalTrials.gov NCT03165734 · fetched Nov 12, 2026
- Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET PatientsPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 2, 2017ClinicalTrials.gov NCT03049189 · fetched Nov 12, 2026